These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34069242)

  • 21. Orange County, California COVID-19 Vaccine Equity Best Practices Checklist: A Community-Centered Call to Action for Equitable Vaccination Practices.
    Washburn KJ; LeBrón AMW; Reyes AS; Becerra I; Bracho A; Ahn E; Urzúa AS; Foo MA; Zárate S; Tanjasiri SP; Boden-Albala B
    Health Equity; 2022; 6(1):3-12. PubMed ID: 35112040
    [No Abstract]   [Full Text] [Related]  

  • 22. Disparities in global COVID-19 vaccination rates & allocation of resources to countries in need.
    Sen-Crowe B; McKenney M; Elkbuli A
    Ann Med Surg (Lond); 2021 Aug; 68():102620. PubMed ID: 34336193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New immunization strategies: adapting to global challenges.
    Mantel C; Cherian T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):25-31. PubMed ID: 31802153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Storage and sterilization techniques: the specific role of the cold chain.
    Guinebault A
    Child Trop; 1986; (162-163):53-68. PubMed ID: 12314980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applying an equity lens in the Decade of Vaccines.
    Brearley L; Eggers R; Steinglass R; Vandelaer J
    Vaccine; 2013 Apr; 31 Suppl 2():B103-7. PubMed ID: 23598470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Vaccine Donations-Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review.
    Su Z; McDonnell D; Li X; Bennett B; Šegalo S; Abbas J; Cheshmehzangi A; Xiang YT
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579261
    [No Abstract]   [Full Text] [Related]  

  • 27. An Implementation Research Approach to Re-orient Health Supply Chains Toward an Equity Agenda in the COVID-19 Era.
    Frisch MF; Scott KW; Binagwaho A
    Ann Glob Health; 2021 Apr; 87(1):42. PubMed ID: 33977085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines.
    Voit K; Timmermann C; Orzechowski M; Steger F
    Front Public Health; 2023; 11():995683. PubMed ID: 36778578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
    Hayman B; Bowles A; Evans B; Eyermann E; Nepomnyashchiy L; Pagliusi S
    Vaccine; 2021 Feb; 39(8):1190-1194. PubMed ID: 33487466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy.
    French J; Deshpande S; Evans W; Obregon R
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic.
    Oehler RL; Vega VR
    Open Forum Infect Dis; 2021 Oct; 8(10):ofab443. PubMed ID: 34646908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
    Fajber K
    Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 Vaccination: Concerns About Its Accessibility, Affordability, and Acceptability.
    Ali I; Ali S; Iqbal S
    Front Med (Lausanne); 2021; 8():647294. PubMed ID: 34336872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines, inspiring innovation in health.
    Pagliusi S; Dennehy M; Kim H;
    Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using a low-cost, real-time electronic immunization registry in Pakistan to demonstrate utility of data for immunization programs and evidence-based decision making to achieve SDG-3: Insights from analysis of Big Data on vaccines.
    Siddiqi DA; Abdullah S; Dharma VK; Shah MT; Akhter MA; Habib A; Khan AJ; Chandir S
    Int J Med Inform; 2021 May; 149():104413. PubMed ID: 33652259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy.
    Finney Rutten LJ; Zhu X; Leppin AL; Ridgeway JL; Swift MD; Griffin JM; St Sauver JL; Virk A; Jacobson RM
    Mayo Clin Proc; 2021 Mar; 96(3):699-707. PubMed ID: 33673921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Vaccine Roll-Out in South Africa and Zimbabwe: Urgent Need to Address Community Preparedness, Fears and Hesitancy.
    Dzinamarira T; Nachipo B; Phiri B; Musuka G
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33809002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decision support system for prioritised COVID-19 two-dosage vaccination allocation and distribution.
    Shahparvari S; Hassanizadeh B; Mohammadi A; Kiani B; Lau KH; Chhetri P; Abbasi B
    Transp Res E Logist Transp Rev; 2022 Mar; 159():102598. PubMed ID: 35185357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.